2.91
(0.00%)
4.80
(0.02%)
-497.09
(-2.64%)
GET IN TOUCH
SEBI presents Samajh Se Investing Simple:
RISK DISCLOSURES ON DERIVATIVES
|
Corporate News 27-Oct-2026 01:45 AstraZeneca India confirms compliance with SEBI regulations for the quarter ending September 30, 2026 AstraZeneca Pharma India Limited informed the BSE Limited and National Stock Exchange of India Ltd. that Integrated Registry Management Services Private Limited, its Registrar and Transfer Agent, has confirmed compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2026. |
INDIAN INDICES
73,609.66 2.91 (0.00%)
22,758.00 4.80 (0.02%)
GLOBAL INDICES
NA
23,219.14 125.76(0.54%)

